Therapeutic Drug Monitoring of Vancomycin Following Critical Care Illnesses: Peak Concentration Determination Maybe Critical
#No Abstract#
Saved in:
Main Authors: | Bita Shahrami (Author), Farhad Najmeddin (Author), Sarah Mousavi (Author), Arezoo Ahmadi (Author), Mojtaba Mojtahedzadeh (Author) |
---|---|
Format: | Book |
Published: |
Research Center for Rational Use of Drugs (RCRUD),
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis
by: Bita Shahrami, et al.
Published: (2020) -
The Controversies Surrounding Tocilizumab Administration Following Pathogen-Associated Molecular Pattern (PAMP) Induced by COVID-19
by: Shayesteh Gheibi, et al.
Published: (2020) -
Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian‐derived area under the curve in critically ill patients with cancer
by: Aseel K. AbuSara, et al.
Published: (2022) -
Oral Substitution of Melatonin in Critical Care: A Pharmacokinetic Study in Patients with Intracranial Hemorrhage
by: Mohammadreza Rouini, et al.
Published: (2020) -
The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries
by: Tijana Kovacevic, et al.
Published: (2019)